Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Xetra  >  Bayer    BAYN   DE000BAY0017

BAYER (BAYN)
My previous session
Most popular
  Report  
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
OFFRE
Quotes 5-day view   Delayed Quote. Delayed Xetra
09/20/2018 09/21/2018 09/24/2018 09/25/2018 09/26/2018 Date
75.82(c) 76.52(c) 76.15(c) 75.6(c) 76.24 Last
5 082 173 8 610 344 2 855 807 3 628 354 549 477 Volume
+2.42% +0.92% -0.48% -0.72% +0.85% Change
More quotes
Financials (EUR)
Sales 2018 39 161 M
EBIT 2018 7 240 M
Net income 2018 4 971 M
Debt 2018 39 542 M
Yield 2018 3,74%
Sales 2019 47 204 M
EBIT 2019 9 618 M
Net income 2019 5 469 M
Debt 2019 36 485 M
Yield 2019 4,03%
P/E ratio 2018 14,65
P/E ratio 2019 14,12
EV / Sales2018 2,81x
EV / Sales2019 2,27x
Capitalization 70 501 M
More Financials
Company
Bayer AG engages in the development, manufacture and distribution of products in the areas of health care, nutrition and high-tech materials.It operates through the following segments: Pharmaceuticals, Consumer Health, Crop Science, Animal Health and Covestro.The Pharmaceuticals segment engages in... 
Sector
Pharmaceuticals
Calendar
11/13Earnings Release
More about the company
Surperformance© ratings of Bayer
Trading Rating : Investor Rating :
More Ratings
Latest news on BAYER
09/25BAYER : Next generation of agricultural talent invited to 'plant their path' at ..
AQ
09/25MONSANTO INDIA : appoints Cherukuri Ravishankar as new MD
AQ
09/24BAYER : Compugen Announces Clinical Milestone Payment in Cancer Immunotherapy Co..
AQ
09/22BAYER : Receives Positive CHMP Opinion for Its Hemophilia a Treatment BAY94-9027
AQ
09/22BAYER : Jivi Approved in Japan for Hemophilia a
AQ
09/21BAYER : collaborates with One Acre Fund to support smallholders in Africa with a..
AQ
09/20BAYER : "Fungicidal Compositions And Methods" in Patent Application Approval Pro..
AQ
09/20MONSANTO : Patent Issued for Plants And Seeds Of Hybrid Corn Variety CH624975 (U..
AQ
09/20BAYER : Compugen earns $7.8m payment from Bayer
AQ
09/20MONSANTO : Patent Application Titled "Containerized Liquid Formulations" Publish..
AQ
More news
Sector news : Pharmaceuticals - NEC
08:15aSHIRE PLC SHIRE PLC : Rule 2.9 Announcement
DJ
09/25EUROPE : Oil boost and Italy budget hopes support European shares
RE
09/25ASTRAZENECA : Positive Data Bolsters Case For AstraZeneca's Imfinzi -- Update
DJ
09/25ASTRAZENECA : Data Show Cancer Drug Imfinzi Reduces Death Risk
DJ
09/25NOVARTIS : to Cut 2,000 Jobs Amid Revamp -- 2nd Update
DJ
More sector news : Pharmaceuticals - NEC
MarketScreener Strategies on BAYER 
BAYER - 09/17
A good timing to anticipate a change in the trend
BUY
BAYER - 07/11
Still trending down
SELL
More Strategies
Latest Tweets
02:51a$BAY001 AG Morningstar | BAYN Updated Forecasts and Estimates from 24 Sep 20.. 
09/24Novartis, Bayer consider appeal as court says Avastin can be used in AMD: Eng.. 
09/24$BAY001 AG Bayers strong competitive positioning in healthcare and crop scie.. 
09/24$879501 AG ADS Bayers strong competitive positioning in healthcare and crop .. 
09/24Stocks to watch: Randgold, Acacia, Tui, Smiths, Comcast, Bayer  
More tweets
Qtime:337
News from SeekingAlpha
09/24DowDuPont And Bayer, Post-Merger Opportunities? 
09/21Feds looking into free services from drug makers - WSJ 
09/21Bayer's Jivi OK'd in Japan for hemophilia A 
09/20Compugen receives milestone payment in cancer immunotherapy collaboration wit.. 
09/19Bayer steps up legal fight over weedkiller, asks court to toss $289M jury awa.. 
Chart BAYER
Duration : Period :
Bayer Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends BAYER
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 26
Average target price 102 €
Spread / Average Target 35%
EPS Revisions
Managers
NameTitle
Werner Baumann Chairman-Management Board
Werner Wenning Chairman-Supervisory Board
Wolfgang U. Nickl Chief Financial Officer
Katharina Jansen Head-Science & Research
Hartmut Klusik Head-Human Resources, Technology & Sustainability
Sector and Competitors
1st jan.Capitalization (M$)
BAYER-25.60%82 922
JOHNSON & JOHNSON2.26%376 847
PFIZER20.90%257 522
NOVARTIS-0.63%217 697
ROCHE HOLDING LTD.-5.48%209 212
MERCK AND COMPANY25.79%188 241